rs80338843
From SNPedia
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(C;C) | 0 | common in clinvar |
(C;T) | 6.2 | Hereditary PGL/PCC Syndrome |
Make rs80338843(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 11 |
Position | 112087916 |
Gene | SDHD, TIMM8B |
is a | snp |
is | mentioned by |
dbSNP | rs80338843 |
dbSNP (classic) | rs80338843 |
ClinGen | rs80338843 |
ebi | rs80338843 |
HLI | rs80338843 |
Exac | rs80338843 |
Gnomad | rs80338843 |
Varsome | rs80338843 |
LitVar | rs80338843 |
Map | rs80338843 |
PheGenI | rs80338843 |
Biobank | rs80338843 |
1000 genomes | rs80338843 |
hgdp | rs80338843 |
ensembl | rs80338843 |
geneview | rs80338843 |
scholar | rs80338843 |
rs80338843 | |
pharmgkb | rs80338843 |
gwascentral | rs80338843 |
openSNP | rs80338843 |
23andMe | rs80338843 |
SNPshot | rs80338843 |
SNPdbe | rs80338843 |
MSV3d | rs80338843 |
GWAS Ctlg | rs80338843 |
Max Magnitude | 6.2 |
ClinVar | |
---|---|
Risk | rs80338843(T;T) |
Alt | rs80338843(T;T) |
Reference | Rs80338843(C;C) |
Significance | Pathogenic |
Disease | Paragangliomas 1 Pheochromocytoma Hereditary Paraganglioma-Pheochromocytoma Syndromes Paraganglioma and gastric stromal sarcoma not provided Hereditary cancer-predisposing syndrome |
Variation | info |
Gene | TIMM8B SDHD |
CLNDBN | Paragangliomas 1 Pheochromocytoma Hereditary Paraganglioma-Pheochromocytoma Syndromes Paraganglioma and gastric stromal sarcoma not provided Hereditary cancer-predisposing syndrome |
Reversed | 0 |
HGVS | NC_000011.9:g.111958640C>T |
CLNSRC | OMIM Allelic Variant |
CLNACC | RCV000007296.2, RCV000007297.2, RCV000020518.1, RCV000227867.1, RCV000486967.1, RCV000492087.1, |
[PMID 10657297] Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.
[PMID 11156372] Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma.
[PMID 11391798] Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.
[PMID 11897817] Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.